Effect of cyclosporin A treatment on the production of antibody in insulin-dependent (type I) diabetic patients

about

T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives The targeting of β-cells by T lymphocytes in human type 1 diabetes: clinical perspectives.

P2860

Q37904710-B2C71D32-6DCE-4A8A-BD14-30B0A2066824 Q38134108-C070E0F7-C89A-4482-ACB3-4B89F83FDC21

P2860

Effect of cyclosporin A treatment on the production of antibody in insulin-dependent (type I) diabetic patients

Item

http://www.wikidata.org/entity/Q35582940

description

1987 nî lūn-bûn

@nan

1987年の論文

@ja

1987年論文

@yue

1987年論文

@zh-hant

1987年論文

@zh-hk

1987年論文

@zh-mo

1987年論文

@zh-tw

1987年论文

@wuu

1987年论文

@zh

1987年论文

@zh-cn

name

Effect of cyclosporin A treatm ...... ent (type I) diabetic patients

@ast

Effect of cyclosporin A treatm ...... ent (type I) diabetic patients

@en

type

Item

label

Effect of cyclosporin A treatm ...... ent (type I) diabetic patients

@ast

Effect of cyclosporin A treatm ...... ent (type I) diabetic patients

@en

prefLabel

Effect of cyclosporin A treatm ...... ent (type I) diabetic patients

@ast

Effect of cyclosporin A treatm ...... ent (type I) diabetic patients

@en

P1476

Effect of cyclosporin A treatm ...... ent (type I) diabetic patients

@en

P2093

Assan R

http://www.w3.org/2001/XMLSchema#string

Bach JF

http://www.w3.org/2001/XMLSchema#string

Boitard C

http://www.w3.org/2001/XMLSchema#string

Debray-Sachs M

http://www.w3.org/2001/XMLSchema#string

Feutren G

http://www.w3.org/2001/XMLSchema#string

Hors J

http://www.w3.org/2001/XMLSchema#string

P2860

Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies

Biological effects of cyclosporin A: a new antilymphocytic agent

Prevention of diabetes mellitus in the BB/W rat with Cyclosporin-A

Selective suppression of an early step in human B cell activation by cyclosporin A.

Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats.

Islet-cell antibodies in diabetes mellitus.

Effects of the new anti-lymphocytic peptide cyclosporin A in animals.

Anti-pancreatic immunity. In vitro studies of cellular and humoral immune reactions directed toward pancreatic islets.

Activation and proliferation signals in mouse B cells. II. Evidence for activation (G0 to G1) signals differing in sensitivity to cyclosporine.

HLA genotype studies in juvenile insulin-dependent diabetes.

P304

1607-1612

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI113247

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Luis Castaño

P577

1987-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

19840593

http://www.w3.org/2001/XMLSchema#string

P698

3316278

http://www.w3.org/2001/XMLSchema#string

P932

442429

http://www.w3.org/2001/XMLSchema#string

Effect of cyclosporin A treatment on the production of antibody in insulin-dependent (type I) diabetic patients

about

P2860

P2860

Effect of cyclosporin A treatment on the production of antibody in insulin-dependent (type I) diabetic patients

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932